New clinical data on Gilead Sciences Inc's experimental antiviral drug remdesivir has raised hopes it might be an effective treatment for the novel coronavirus that has infected more than 3 million people and killed over 225,000 worldwide.
UK: Explainer: What does new data say about Gilead's experimental coronavirus drug?
Reviewed by Shahid Karimi
on
April 29, 2020
Rating: 5
No comments: